KARSIVAN 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA PARA PERROS
KARSIVAN 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA PARA PERROS
Authorised
- Propentofylline
Product identification
Medicine name:
KARSIVAN 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA PARA PERROS
Active substance:
- Propentofylline
Target species:
-
Dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Propentofylline50.00/milligram(s)1.00Tablet
Pharmaceutical form:
-
Coated tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QC04AD90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Spain
Package description:
- Available only in Spanish
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Merck Sharp & Dohme Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
- Intervet GesmbH
Responsible authority:
- Spanish Agency For Medicines And Medical Devices
Authorisation number:
- 1055 ESP
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 30/10/2025
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 30/10/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Spanish (PDF)
Published on: 21/06/2024
